The researches in the medicinal chemistry are remarkable due to its essential role for human life. Pyrazolo-pyrimidines show a vast contribution towards drug chemistry by acting as an antagonist to several diseases of man. This work reported the synthesis of 6-bromo-pyrazolo-[1,5-a]-pyrimidine-3-ethylcarboxylate (5) by changing bases for succesive trials under microwave conditions from 5-ammino-1H-pyrazole-4carboxylate (3) [1-5]. Reaction time for a strong base like KOH completed at the least time. This inference emerged a new trend for the study of chemical kinetics of organic synthesis. In this article, quantitative synthetic studies of 5-amino-1H-pyrazole-4-carboxylate (3) using different nano metaloxide catalysts is reported [6]. α-Fe 3 O 4 afforded highest yield among four different catalysts used. The compound 5 was screened for the biological activity as CDKs inhibitor with the reference compound roscovitine [7]. It proved as a better potent inhibitor for CDK4 & CDK6 (IC 50) than roscovitine. EXPERIMENTAL All the chemicals including nano-catalysts used were purchased from Sigma-Aldrich (AR) and Merck. Melting points were determined in open capillary tubes in Buchi B-540 melting point apparatus and are uncorrected. The reaction was monitored by thin layer chromatography using silica gel
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.